HRS4R
Vull donar
Firma
FERRAN DÍAZ-ROLDAN
Posició
Investigador/a Post-doctoral – R2
Investigadors/es Post-doctorals – R2

Projectes

Codi oficial: ICI21/00005 Data inici: 01/01/2022 Data fi: 31/12/2025 Investigador/a principal: ABEL LÓPEZ BERMEJO Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: PI22/00366 Data inici: 01/01/2023 Data fi: 31/12/2025 Investigador/a principal: ABEL LÓPEZ BERMEJO Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: ICI21/00005 Data inici: 01/01/2022 Data fi: 31/12/2025 Investigador/a principal: ABEL LÓPEZ BERMEJO Organisme finançador: INSTITUTO DE SALUD CARLOS III

Publicacions

Carreras-Badosa G, Puerto-Carranza E, Mas-Parés B, Gómez-Vilarrubla A, Cebrià-Fondevila H, Díaz-Roldán F, Riera-Pérez E, de Zegher F, Ibañez L, Bassols J, López-Bermejo A

Circulating free T3 associates longitudinally with cardio-metabolic risk factors in euthyroid children with higher TSH

Frontiers in Endocrinology, 2023, 14, 1172720-1172720 dx.doi.org/10.3389/fendo.2023.1172720
Carreras-Badosa G, Puerto-Carranza E, Mas-Parés B, Gómez-Vilarrubla A, Gómez-Herrera B, Díaz-Roldán F, Riera-Pérez E, de Zegher F, Ibañez L, Bassols J, López-Bermejo A

Higher levels of serum a-Klotho are longitudinally associated with less central obesity in girls experiencing weight gain

Frontiers in Endocrinology, 2023, 14, 1218949-1218949 dx.doi.org/10.3389/fendo.2023.1218949
Carreras-Badosa G, Gómez-Vilarrubla A, Mas-Parés B, Martínez-Calcerrada JM, Xargay-Torrent S, Prats-Puig A, Puerto-Carranza E, Díaz-Roldán F, de Zegher F, Ibañez L, Bassols J, López-Bermejo A

A 24-month metformin treatment study of children with obesity: Changes in circulating GDF-15 and associations with changes in body weight and visceral fat

Pediatric Obesity, 2022, 17 dx.doi.org/10.1111/ijpo.12845
Bassols J, Martínez-Calcerrada JM, Osiniri I, Díaz-Roldán F, Xargay-Torrent S, Mas-Parés B, Dorado-Ceballos E, Prats-Puig A, Carreras-Badosa G, de Zegher F, Ibáñez L, López-Bermejo A

Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study

Plos One, 2019, 14 dx.doi.org/10.1371/journal.pone.0226303
Xargay-Torrent S, Espuña-Capote N, Montesinos-Costa M, Prats-Puig A, Carreras-Badosa G, Díaz-Roldán F, De Zegher F, Ibáñez L, Bassols J, López-Bermejo A

Serum alkaline phosphatase relates to cardiovascular risk markers in children with high calcium-phosphorus product

SCIENTIFIC REPORTS, 2018, 8, 17864-17864 dx.doi.org/10.1038/s41598-018-35973-5
Carreras-Badosa G, Armero-Bujaldón C, Solé-Amat L, Prats-Puig A, Díaz-Roldán F, Soriano-Rodriguez P, de Zegher F, Ibañez L, Bassols J, López-Bermejo A

Serum 25-hydroxyvitamin D and cardiovascular disease risk factors in women with excessive weight gain during pregnancy and in their offspring at age 5-6 years

INTERNATIONAL JOURNAL OF OBESITY, 2018, 42, 1019-1028 dx.doi.org/10.1038/s41366-018-0101-6
Bassols J, Prats-Puig A, Gispert-Saüch M, Crehuet-Almirall M, Carreras-Badosa G, Díaz-Roldán F, Montesinos-Costa M, de Zegher F, Ibáñez L, López-Bermejo A

Increased serum IgG and IgA in overweight children relate to a less favourable metabolic phenotype.

Pediatric Obesity, 2013, 9, 232-238 dx.doi.org/10.1111/j.2047-6310.2013.00160.x

Formulari de contacte

Coneix l’IDIBGI!

menu